Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the U.S. Food and Drug...
NuVasive, Inc, the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that it received 510(k)...
Sentient, LLC announced the U.S. introduction of Sentient Sculpt, the first non-invasive professional electromagnetic wave and microwave treatment for cellulite reduction that consistently produces...
Ligand Pharmaceuticals Incorporated announced that its partner Travere Therapeutics, Inc. has received accelerated approval from the U.S. Food and Drug Administration for FILSPARI to...
